Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Alpha-1 Blockade for Alcohol Use Disorder (AUD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial led by Brown University is evaluating alpha-1 blockade as a treatment for Alcohol Use Disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-1 blocker (investigational)

Snippet

Sponsor: Brown University | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: RECRUITING